Skip to main content
1-800-833-0680NET 30 Available
12 Panel Magenta Urine Cup test device showing result windows for Amphetamine, Barbiturates, Buprenorphine, Benzodiazepines and 8 more analytes
1 / 4

12 Panel Magenta Urine Cup

★★★★★4.8(12 reviews)
FDA 510(k) FDA 510(k) ClearedCLIA WaivedIn Stock

12-panel integrated urine cup screening for Amphetamine, Barbiturates, Buprenorphine, and 9 more. Manufacturer SKU MGDSDOA-6125.

Volume Pricing

QuantityUnit Price
1–4 packs25–100 testsCurrent$2.95/test
5–20 packs125–500 tests$2.69/test
21–80 packs525–2,000 tests$2.49/test
81+ packs2,025+ tests$2.39/test

Quantity (packs)

= 25 tests
1 pack·$2.95/test$73.75

Add 4 more packs to unlock $2.69/test

  • Ships today if ordered by 3pm ET
  • 30-day satisfaction guarantee
  • Bulk pricing available — request a quote
FDA Clearance
FDA 510(k) Cleared
CLIA Status
Waived
Panels
12
Result Time
5 min
Shelf Life
Up to 36 mo
Pack Sizes
25

12 Panel Magenta Urine Cup is a 12-panel integrated urine cup from Magenta (manufacturer SKU MGDSDOA-6125). It screens for Amphetamine, Barbiturates, Buprenorphine, and 9 more in a single device, with each analyte and cutoff drawn directly from the manufacturer's panel specification.

The device tests for the following 12 analytes at the cutoffs printed on the package insert:

  • Amphetamine (AMP): 1000 ng/mL
  • Barbiturates (BAR): 300 ng/mL
  • Buprenorphine (BUP): 10 ng/mL
  • Benzodiazepines (BZO): 300 ng/mL
  • Cocaine (COC): 300 ng/mL
  • Ecstasy (MDMA): 500 ng/mL
  • Methamphetamine (MET): 1000 ng/mL
  • Morphine / Opiates (MOP): 300 ng/mL
  • Methadone (MTD): 300 ng/mL
  • Oxycodone (OXY): 100 ng/mL
  • Phencyclidine (PCP): 25 ng/mL
  • Marijuana (THC): 50 ng/mL

Because this is an integrated urine cup, donor specimen and immunoassay strips reside in the same device. That eliminates the manual transfer step otherwise required when running a separate collection cup and dip card, which reduces the chance of cross-contamination, specimen loss, and chain-of-custody questions at the point of collection. The collector hands the cup to the donor, the donor voids directly into the cup, and the collector secures the cap to activate the device — there is no pour-off and no separate test strip handling.

Per the manufacturer SKU line in the owner's catalog, this device is labeled CLIA-Waived / FDA / OTC — suitable for moderate-complexity workplace, clinical, and behavioral-health screening programs operating under CLIA-waived certification.

Typical buyers are workplace drug-testing programs, drug courts, behavioral-health and substance-use treatment centers, primary care and urgent care clinics, and pre-employment screeners.

When evaluating an integrated urine cup for your program, weigh the panel breadth against the cutoff levels — lower cutoffs catch more cases but increase the rate of presumptive positives that must go to a confirmation laboratory, raising your per-collection cost. Also confirm whether adulterant strips are integrated on the cup itself or are sold as a separate add-on, and check the cup's specimen capacity, since split-specimen workflows require enough volume to fill both the screening cup and a sealed B-bottle for laboratory confirmation.

Manufacturer SKU: MGDSDOA-6125. Always read the lot number, expiration date, and proper read window from the package insert that ships with the device.

About the 12 Panel Magenta Urine Cup

12 Panel Magenta Urine Cup is a 12-panel integrated urine cup from Magenta (manufacturer SKU MGDSDOA-6125). It screens for Amphetamine, Barbiturates, Buprenorphine, and 9 more in a single device, with each analyte and cutoff drawn directly from the manufacturer's panel specification.

The device tests for the following 12 analytes at the cutoffs printed on the package insert:

  • Amphetamine (AMP): 1000 ng/mL
  • Barbiturates (BAR): 300 ng/mL
  • Buprenorphine (BUP): 10 ng/mL
  • Benzodiazepines (BZO): 300 ng/mL
  • Cocaine (COC): 300 ng/mL
  • Ecstasy (MDMA): 500 ng/mL
  • Methamphetamine (MET): 1000 ng/mL
  • Morphine / Opiates (MOP): 300 ng/mL
  • Methadone (MTD): 300 ng/mL
  • Oxycodone (OXY): 100 ng/mL
  • Phencyclidine (PCP): 25 ng/mL
  • Marijuana (THC): 50 ng/mL

Because this is an integrated urine cup, donor specimen and immunoassay strips reside in the same device. That eliminates the manual transfer step otherwise required when running a separate collection cup and dip card, which reduces the chance of cross-contamination, specimen loss, and chain-of-custody questions at the point of collection. The collector hands the cup to the donor, the donor voids directly into the cup, and the collector secures the cap to activate the device — there is no pour-off and no separate test strip handling.

Per the manufacturer SKU line in the owner's catalog, this device is labeled CLIA-Waived / FDA / OTC — suitable for moderate-complexity workplace, clinical, and behavioral-health screening programs operating under CLIA-waived certification.

Typical buyers are workplace drug-testing programs, drug courts, behavioral-health and substance-use treatment centers, primary care and urgent care clinics, and pre-employment screeners.

When evaluating an integrated urine cup for your program, weigh the panel breadth against the cutoff levels — lower cutoffs catch more cases but increase the rate of presumptive positives that must go to a confirmation laboratory, raising your per-collection cost. Also confirm whether adulterant strips are integrated on the cup itself or are sold as a separate add-on, and check the cup's specimen capacity, since split-specimen workflows require enough volume to fill both the screening cup and a sealed B-bottle for laboratory confirmation.

Manufacturer SKU: MGDSDOA-6125. Always read the lot number, expiration date, and proper read window from the package insert that ships with the device.